Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Fujian Aonong Biological Technology Grouporp's interest expense for the
three
months ended in Mar. 2026 was ¥ -25 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-132 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Fujian Aonong Biological Technology Grouporp's Interest Expense for the
three
months ended in Mar. 2026 was ¥-25 Mil. Its
Operating Income
for the
three
months ended in Mar. 2026 was ¥-45 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Mar. 2026 was ¥1,422 Mil.
Fujian Aonong Biological Technology Grouporp's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as
Fujian Aonong Biological Technology Grouporp did not have earnings to cover the interest expense.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Fujian Aonong Biological Technology Grouporp Interest Expense Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-132 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fujian Aonong Biological Technology Grouporp (SHSE:603363) has a Interest Expense of ¥-132 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors.
Is Fujian Aonong Biological Technology Grouporp's Interest Expense too high?
Fujian Aonong Biological Technology Grouporp's current Interest Expense is ¥-132 Mil. Overall, Fujian Aonong Biological Technology Grouporp has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fujian Aonong Biological Technology Grouporp's Interest Expense compare to ADM and BG?
Fujian Aonong Biological Technology Grouporp's Interest Expense of ¥-132 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Consumer Packaged Goods company?
A good Interest Expense depends on the Consumer Packaged Goods industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Fujian Aonong Biological Technology Grouporp and its competitors. Fujian Aonong Biological Technology Grouporp's current Interest Expense is ¥-132 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fujian Aonong Biological Technology Grouporp stock overvalued right now?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp (SHSE:603363) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.31, compared to a current price of ¥2.94 — trading 124.4% above its estimated fair value. The current Interest Expense is ¥-132 Mil. Fujian Aonong Biological Technology Grouporp's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Fujian Aonong Biological Technology Grouporp (SHSE:603363), the current Interest Expense is ¥-132 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fujian Aonong Biological Technology Grouporp (SHSE:603363) Overvalued in 2026?
Based on GuruFocus' analysis, Fujian Aonong Biological Technology Grouporp stock appears to be overvalued.
The current stock price of ¥2.94 is trading 124.4% above its estimated GF Value™ of ¥1.31.
GuruFocus considers Fujian Aonong Biological Technology Grouporp to be Significantly Overvalued.
Key valuation signals for SHSE:603363:
Interest Expense: ¥-132 Mil
GF Value™: ¥1.31 vs. price of ¥2.94 (124.4% above fair value)
No single metric tells the full story. See the SHSE:603363 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fujian Aonong Biological Technology Group Incorp Ltd is an agricultural and animal husbandry enterprise in China. The principal business activities of the company include feed-oriented service, animal protection, pig raising, and raw material trade. In addition, the company's insurance business mainly relies on the feed marketing system throughout the country to provide downstream farmers with relevant products for disease prevention and control.
34GF Score
Get the complete analysis for SHSE:603363
Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603363 has been successfully added to your 
